A carregar...
Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy
Probenecid has been used for decades in the treatment of gout but recently has also been found to improve outcomes in patients with heart failure via stimulation of the transient receptor potential vanilloid 2 (TRPV2) channel in cardiomyocytes. This study tested the use of probenecid on a novel mous...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7100971/ https://ncbi.nlm.nih.gov/pubmed/32218573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0230386 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|